JM

Jal Manekji Turel

Director Director DIN 01030193
DIN 01030193 First appointment May 1997 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 3 historical roles
Total affiliations 3 Since May 1997
Shareholding value •••• Premium profile

About Jal Manekji Turel

Data last updated:

Jal Manekji Turel was a Director at Atul Bioscience Limited (1997–2008), Director at Aagam Holdings Private Limited (2005–2013) and Director at Atro Limited (1999–2013). The companies operate in Pharma, Financial Services and Chemicals.

DIN 01030193
Primary Designation Director
Industry Pharma
First Appointment 21 May 1997

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Atul Bioscience Limited U24230GJ1997PLC032369
Director21 May 19971997₹137 Cr (FY 2025)Active
Aagam Holdings Private Limited U51900GJ1984PTC074539
Director22 Nov 20051984₹28.66 Cr (FY 2023)Active
Atro Limited U24110GJ1999PLC035663
Director26 Mar 19991999Under Liquidation

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Atul Bioscience Limited
Aagam Holdings Private Limited
Atro Limited
Premium access

Shareholding and investment profile for Jal Manekji Turel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jal Manekji Turel

Jal Manekji Turel was first appointed on 21 May 1997 as Director at Atul Bioscience Limited. The most recent appointment on record is 22 Nov 2005 at Aagam Holdings Private Limited.

Jal Manekji Turel held 3 earlier board appointments: Atul Bioscience Limited (Director, 21 May 1997 to 11 Dec 2008); Aagam Holdings Private Limited (Director, 22 Nov 2005 to 23 Jun 2013); Atro Limited (Director, 26 Mar 1999 to 23 Jun 2013).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available